Hemodialysis Complication Clinical Trial
Official title:
Interval Versus Continous Intradialytic Training on Muscla Quality Index and Functional Capacity in Hemodialysis Patients
Verified date | September 2023 |
Source | Cairo University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this study is to find out the effect of interval versus continous intradialytic training on muscle quality index and functional capacity in Hemodialysis patients. The main question it aims to answer is: Does interval versus continous intradialytic training have an effect on muscle quality index and functional capacity in hemodialysis patients? Patients will be assigned randomly by computerized block randomization into two groups:Group (A): 30 patients will participate in 8 weeks of aerobic exercise in the form of high intensity interval training (HIIT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week).Group (B): 30 patients will participate in 8 weeks of aerobic exercise in the form of moderate intensity continous training (MICT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week) . primary and secondary variables will be measured before starting treatment and after completion (after 2 months )
Status | Completed |
Enrollment | 60 |
Est. completion date | September 10, 2023 |
Est. primary completion date | September 10, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 45 Years to 55 Years |
Eligibility | Inclusion Criteria: 1. Age between 45- 55 years. 2. Male sex included. 3. Patients with grade 5 chronic renal failure on hemodialysis. 4. Patients are on hemodialysis for 1-3 years. 5. Body mass index (BMI) range from 25-34.9 Kg/m2. 6. They will be medically and psychologically stable. 7. Receiving their physician-prescribed pharmacotherapy regularly. 8. Agree to participate by signing an informed consent form. Exclusion Criteria: 1. Inability to comprehend and follow instructions as in dementia or speech problems such as dysphasia. 2. Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, persistent systolic blood pressure (BP) greater than 200 mmHg, persistent diastolic BP greater than 120 mmHg, acute pericarditis or myocarditis. 3. Acute systemic infection. 4. Presence of malignant disease. 5. Patients with Diabetes Mellitus. 6. Patients with Lupus Nephritis. 7. Patients with chronic obstructive lung disease, restrictive lung disease or chronic chest infection. 8. Severe obesity (BMI > 35). 9. Chronic inflammatory orthopedic disorders and rheumatoid arthritis. 10. Patients with muscle injuries or neuromuscular disorders (muscular dystrophy, myasthenia gravis, myopathy, multiple sclerosis and peripheral neuropathy). |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of physical therapy, cairo university | Cairo | Dokki |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | muscle quality index | The MQI was quantified using a timed sit-to-stand test, body mass, and leg length to calculate a power index that is expressed in watts (W). The MQI was calculated as follows:
QI (Watts) = ((Leg length×0.4) ×Bodymass×gravity×10) / Time taken for (sit to stand 5 times) Body mass will be measured using a digital scale. Leg length will be taken using tape measure to measure the distance (in meters) from the greater trochanter of the femur to the lateral malleolus, measured from standing position . BY using a stopwatch, sit-to-stand time will be calculated as the time to stand from a seated position and return to sitting consecutively five times. The use of arms not allowed during the sit-to-stand test. Acceleration of gravity (9.8 m/s2). After measuring leg length, body mass and time for sit to stand, all these data will be written in the previous equation to calculate muscle quality index and expressed in watts (W). |
2 months | |
Primary | six minute walk test | Six minute walk test (6MWT) to assess physical functional capacity (using stopwatch, colored tape to mark starting line and end line of corridor) Using a stopwatch, assess physical functional capability. The 6MWT will be conducted indoors along a 30 m long, level, straight, enclosed hallway, with the length of the corridor indicated with brightly coloured tape at the beginning and end lines. Subjects will be advised to walk as far as possible from end to end of the corridor without jogging or running, and to cover as much distance as feasible in the 6 minute time limit . This test was performed at the beginning of treatment and at the end of treatment program (8 weeks) to assess functional performance difference. | 2 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05980845 -
The Effect Nature Sounds and Music on Hemodialysis Patients
|
N/A | |
Recruiting |
NCT05020717 -
Retrospective Survey of Hyperkalemia in Hemodialysis
|
||
Recruiting |
NCT04046042 -
Virtual Reality Intradialysis: Last vs. First Part of the Session
|
N/A | |
Recruiting |
NCT04094038 -
The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients
|
Phase 4 | |
Completed |
NCT03311581 -
The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery
|
Phase 1 | |
Completed |
NCT05531175 -
REIKI APPLICATION PAIN, FATIGUE AND ITCHING IN HEMODIALYSIS PATIENTS
|
N/A | |
Completed |
NCT03061552 -
Inferior Vena Cava Sonography in Hemodialysis Patients and Quality of Life
|
N/A | |
Completed |
NCT04057313 -
Coffee in Hemodialysis and Headache
|
N/A | |
Completed |
NCT03251573 -
The Cohort Study of Cognitive Impairment in Chinese Hemodialysis Patients
|
||
Completed |
NCT05568342 -
The Effect of Roy Adaptation-Based Nursing Intervention
|
N/A | |
Completed |
NCT03527680 -
Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis
|
N/A | |
Completed |
NCT04063423 -
Non- Clinical Coagulation Activation During Hemodialysis
|
||
Active, not recruiting |
NCT06203795 -
Dialysis Performance of the FX CorAL Membrane
|
N/A | |
Completed |
NCT04319328 -
Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?
|
||
Completed |
NCT03627884 -
Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
|
Phase 4 | |
Completed |
NCT05132036 -
Lung Ultrasound Assessment of Fluid Overload in Haemodialysis Patients
|
N/A | |
Completed |
NCT03076528 -
An Innovative Virtually Supervised Exercise for Dialysis Patients
|
Phase 2 | |
Completed |
NCT06098443 -
Acupressure Versus Transcutaneous Electrical Nerve Stimulation on Pain and Quality of Life Intradialysis
|
N/A | |
Completed |
NCT04645121 -
Carbon Monoxide-based Rebreathing Method and Bioimpedance in Hemodialysis Patients
|
||
Recruiting |
NCT04127877 -
Bio Impedance-assisted Monitoring of Chronic Hemodialysis Patients
|
N/A |